Diabetic nephropathy in African Americans

Authors
Citation
Ed. Crook, Diabetic nephropathy in African Americans, AM J HYPERT, 14(6), 2001, pp. 132S-138S
Citations number
63
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
AMERICAN JOURNAL OF HYPERTENSION
ISSN journal
08957061 → ACNP
Volume
14
Issue
6
Year of publication
2001
Part
2
Supplement
S
Pages
132S - 138S
Database
ISI
SICI code
0895-7061(200106)14:6<132S:DNIAA>2.0.ZU;2-K
Abstract
Diabetic nephropathy (DN) is the number one cause of end-stage renal diseas e in United States and is highly prevalent in African Americans. We have fo und that among African Americans in Mississippi diabetic nephropathy appear s to affect females more than males, which may be related to increased rate s of obesity and diabetes in African American women. Glycemic control and c ontrol of blood pressure is essential to prolong renal survival and to prot ect against cardiovascular events. Angiotensin-converting enzyme inhibitors reduce cardiovascular mortality in diabetics and are tolerated in advanced renal disease. The impact of glycemic control, appropriate antihypertensiv es, and the optimal level of blood pressure control in African Americans wi th advanced DN require further study. This article reviews the impact, clin ical characteristics, risk factors, and treatment of diabetic nephropathy i n African Americans. Am J Hypertens 2001; 14:132S-138S (C) 2001 American Jo urnal of Hypertension, Ltd.